Black Diamond Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BDTX research report →
About the company
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor.
- CEO
- Mark A. Velleca
- IPO
- 2020
- Employees
- 24
- HQ
- Cambridge, MA, US
Price Chart
- Market Cap
- $115.18M
- P/E
- -2.66
- P/S
- 0.00
- P/B
- 1.10
- EV/EBITDA
- -2.70
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -36.37%
- ROIC
- -43.60%
- Revenue
- $70.00M · 0.00%
- Net Income
- $22.37M · 132.10%
- EPS
- $0.39 · 130.71%
- Op Income
- $19.87M
- FCF YoY
- 147.53%
- 52W High
- $4.94
- 52W Low
- $1.60
- 50D MA
- $2.36
- 200D MA
- $2.82
- Beta
- 3.23
- Avg Volume
- 1.70M
Get TickerSpark's AI analysis on BDTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 26, 26 | Behbahani Ali | other | 40,000 |
| Jun 26, 26 | Kulkarni Samarth | other | 40,000 |
| Jun 26, 26 | Menzel Garry E | other | 40,000 |
| Jun 26, 26 | Raman Prakash | other | 40,000 |
| Jun 26, 26 | Dhingra Kapil | other | 40,000 |
| Jun 26, 26 | Campbell Shannon | other | 40,000 |
| Jun 19, 26 | Behbahani Ali | other | 8,961 |
| Jun 19, 26 | Raman Prakash | other | 7,907 |
| Mar 20, 26 | Behbahani Ali | other | 6,919 |
| Mar 20, 26 | Raman Prakash | other | 6,105 |
Our BDTX coverage
Recent articles, reports, and earnings notes.
No research on BDTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BDTX report →Similar companies
Peers in the same neighborhood.